The significance of tumor microenvironment for immunotherapy in melanoma and non-melanoma skin cancer
Immune checkpoint inhibitors (ICIs), such as anti-PD-1 antibody, have significantly changed the treatment landscape not only for unresectable melanoma but also for non-melanoma skin cancers. In addition, anti-PD-1 antibody administration methods have evolved and are now used in both the neoadjuvant...
Saved in:
| Main Author: | Taku Fujimura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-08-01
|
| Series: | Immunological Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/25785826.2025.2550795 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01) -
Editorial: The tumor microenvironment and immunotherapy for head and neck tumors
by: Yifan Jiang, et al.
Published: (2025-06-01) -
Advances in the immunological microenvironment and immunotherapy of bladder cancer
by: Le Meng, et al.
Published: (2025-08-01) -
Opportunities, obstacles and challenges of nano-immunotherapy in melanoma
by: Zexing Shan, et al.
Published: (2025-08-01) -
Research progress on mechanisms of tumor immune microenvironment and gastrointestinal resistance to immunotherapy: mini review
by: Zheng Zhang, et al.
Published: (2025-07-01)